Ad is loading...
RNWCX
Price
$79.22
Change
+$0.05 (+0.06%)
Updated
Nov 22 closing price
RNWFX
Price
$81.24
Change
+$0.05 (+0.06%)
Updated
Nov 22 closing price
Ad is loading...

RNWCX vs RNWFX

Header iconRNWCX vs RNWFX Comparison
Open Charts RNWCX vs RNWFXBanner chart's image
American Funds New World R3
Price$79.22
Change+$0.05 (+0.06%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$81.24
Change+$0.05 (+0.06%)
VolumeN/A
CapitalizationN/A
RNWCX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RNWCX vs. RNWFX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNWCX is a Buy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWCX (63B) and RNWFX (63B) have equal amount of cash in the bank . RNWFX pays higher dividends than RNWCX: RNWFX (1.51) vs RNWCX (1.00). RNWCX was incepted earlier than RNWFX: RNWCX (22 years) vs RNWFX (23 years). RNWCX (32.00) and RNWFX (32.00) have comparable annual turnover. RNWCX (250) and RNWFX (250) have matching initial minimum investment requirements. RNWFX annual gain was more profitable for investors over the last year : 11.63 vs. RNWCX (10.92). RNWFX return over 5 years is better than : 18.28 vs. RNWCX (16.33).
RNWCXRNWFXRNWCX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years23 years-
Gain YTD7.3647.93793%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets63B63B100%
Annual Yield % from dividends1.001.5167%
Returns for 1 year10.9211.6394%
Returns for 3 years-12.26-11.11110%
Returns for 5 years16.3318.2889%
Returns for 10 years37.3740.7892%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NWS32.110.42
+1.33%
News Corp
CDIO0.25N/A
+1.31%
Cardio Diagnostics Holdings
QRTEB3.02N/A
N/A
Qurate Retail
QFIN35.21-0.04
-0.11%
Qifu Technology
CATX3.00-3.17
-51.38%
Perspective Therapeutics